Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3+IL-17+ cells

MLA

K L Del Bel, et al. “Pre-Diagnostic Genotyping Identifies T1D Subjects with Impaired Treg IL-2 Signaling and an Elevated Proportion of FOXP3+IL-17+ Cells.” Genes & Immunity, vol. 18, Jan. 2017, pp. 15–21. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8121a17d679d2cf96b75a8834773bce4&authtype=sso&custid=ns315887.

APA

K L Del Bel, Stuart E. Turvey, Catherine M. Biggs, John J. Priatel, Aaron F. Hirschfeld, S Staiger, Ashish Marwaha, Constadina Panagiotopoulos, & Rusung Tan. (2017). Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3+IL-17+ cells. Genes & Immunity, 18, 15–21.

Chicago

K L Del Bel, Stuart E. Turvey, Catherine M. Biggs, John J. Priatel, Aaron F. Hirschfeld, S Staiger, Ashish Marwaha, Constadina Panagiotopoulos, and Rusung Tan. 2017. “Pre-Diagnostic Genotyping Identifies T1D Subjects with Impaired Treg IL-2 Signaling and an Elevated Proportion of FOXP3+IL-17+ Cells.” Genes & Immunity 18 (January): 15–21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8121a17d679d2cf96b75a8834773bce4&authtype=sso&custid=ns315887.